Cargando…

Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development

Immunotherapy has been recently considered as a promising alternative for cancer treatment. Indeed, targeting of immune checkpoint (ICP) strategies have shown significant success in human malignancies. However, despite remarkable success of cancer immunotherapy in pancreatic cancer (PCa), many of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiaie, Seyed Hossein, Sanaei, Mohammad Javad, Heshmati, Masoud, Asadzadeh, Zahra, Azimi, Iman, Hadidi, Saleh, Jafari, Reza, Baradaran, Behzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144893/ https://www.ncbi.nlm.nih.gov/pubmed/34094821 http://dx.doi.org/10.1016/j.apsb.2020.12.011

Ejemplares similares

Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
por: Kiaie, Seyed Hossein, et al.
Publicado: (2023)

Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
por: Kiaie, Seyed Hossein, et al.
Publicado: (2023)

Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
por: Bagherifar, Rafieh, et al.
Publicado: (2021)

Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
por: Aslan, Cynthia, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
por: Makaremi, Shima, et al.
Publicado: (2021)

The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
por: Hassanian, Hamidreza, et al.
Publicado: (2022)

Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer
por: HEMMAT, NIMA, et al.
Publicado: (2022)

Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications
por: Amiri, Ala, et al.
Publicado: (2022)

Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
por: Rezasoltani, Sama, et al.
Publicado: (2020)

Checkpoint Immunotherapy-Induced Myocarditis and Encephalitis Complicated With Complete AV Block: Not All Hope Is Lost
por: Lorente-Ros, Álvaro, et al.
Publicado: (2022)

Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy
por: Amir Taghavi, Bita, et al.
Publicado: (2022)

Associations of Spiritual Well-Being and Hope with Health Anxiety Severity in Patients with Advanced Coronary Artery Disease
por: Heshmati, Rasoul, et al.
Publicado: (2021)

Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022)

Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
por: Kiaie, Seyed Hossein, et al.
Publicado: (2022)

Advances in immunotherapy for COVID-19: A comprehensive review
por: Masoomikarimi, Masoomeh, et al.
Publicado: (2021)

Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs
por: Derakhshani, Afshin, et al.
Publicado: (2021)

The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering
por: Sadidi, Hossein, et al.
Publicado: (2020)

MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review
por: Shams, Roshanak, et al.
Publicado: (2020)

The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?
por: Krzyżanowska, Natalia, et al.
Publicado: (2022)

FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
por: Symeonides, Stefan N., et al.
Publicado: (2017)

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
por: Shekari, Najibeh, et al.
Publicado: (2023)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Allergen-Specific Immunotherapy in Food Allergy: There Is Hope
por: Ring, Johannes
Publicado: (2008)

Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Immunotherapy: A New Hope for Cancer Patients
por: Gupta, Shalini, et al.
Publicado: (2020)

High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019)

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
por: Jin, Ketao, et al.
Publicado: (2021)

Immunotherapy for multiple myeloma: new chances and hope
por: Xu, Jingyu, et al.
Publicado: (2023)

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
por: Asadzadeh, Zahra, et al.
Publicado: (2020)

Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
por: Zhang, Zeng, et al.
Publicado: (2022)

Varied functions of immune checkpoints during cancer metastasis
por: Safarzadeh, Ali, et al.
Publicado: (2020)

Cellular immunotherapy as a beacon of hope for hematological malignancies
por: Lee, Hyun-Ju, et al.
Publicado: (2015)

Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020)

Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2020)

Immunotherapy in Thoracic Malignancies: New Treatment and New Hope
por: Melosky, Barbara
Publicado: (2022)

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
por: Davar, Diwakar, et al.
Publicado: (2022)

Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients
por: Yan, Dan
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eubhlnrc56klnd2kq6eepiec5e